Barchart111d agoneutral
How to Play QNT Stock After the Quantinuum IPOQuantinuum’s IPO grabbed headlines, but its first trading day showed both excitement and caution. How can investors approach QNT stock after its Wall Street debut?
Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
143last 24h
876last 7d
147● bullish (7d)
98● bearish (7d)
214publishers
Bloomberg112d agoneutral
Honeywell-Backed Quantinuum Shares Jump 13% After Upsized IPO(Bloomberg) -- Quantinuum Inc., a quantum computing company backed by Honeywell International Inc., opened 13% above its listing price after raising $1.68 billion in an upsized US initial public offering.Most Read from BloombergGlazer Family Members Study Manchester United Stake SaleRepublican-Led House Votes to Stop Iran War, Rebuking TrumpTrump Begins Rebuilding His Tariff Wall, Citing Forced LaborBroadcom Slides by Most in More Than a Year on AI Outlook MissStock Buyers Step In to Lift Dow Av
The Wall Street Journal120d agoneutral
A New, Powerful Cholesterol-Lowering Drug Is on the HorizonPharmaceutical companies have spent years targeting a common blood particle associated with heart-attack risks.
Bloomberg121d agoneutral
Honeywell-Backed Quantinuum Seeks to Raise $1.05 Billion in IPO(Bloomberg) -- Quantinuum Inc., a quantum computing company backed by Honeywell International Inc., is seeking to raise $1.05 billion in its US initial public offering, capitalizing on investor enthusiasm for the technology. Most Read from BloombergNvidia CEO Urges Super Micro to Tighten Up on ComplianceTrump Doctor Visit Renews Health Scrutiny as 80th Birthday NearsTrump Says He’ll Announce Negotiated Deal With Iran ShortlyRubio Sees Good News Coming on Hormuz as Iran Talks ContinueUS, Iran Inc
The Wall Street Journal126d agoneutral
Amgen Drug Gets New Warnings in Japan After Patient DeathsThe Japanese drugmaker that sells rare-disease medicine Tavneos said new patients will be able to get the drug, which carries risk of liver injury.